Skip to content
MNOVMedicinova Inc

Earnings

When Medicinova Inc reports, what it reported each quarter, and how the stock took the results.

58 quarters. Jun 30, 2010 to Jun 30, 2026. USD.

Next results · Q3 2026Projected

Dec 7, after the close

Mon, Dec 7, 2026in 37 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q3 2026 · Ended Sep 30, 2026
10-Q window
Nov 5 – 16

Read against Q3 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$123.32K
Revenue, change from a year earlier: Q2 2026 +240.6%, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m
Net income
-$3.05M
Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
EPS
-$0.06
EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m

Quarter by quarter

Q2 2026$458.44K+240.6% vs Q2 2025

Latest results

  1. Q2 2026Aug 13, 2026, after the close+0.4%by the close of Aug 17
    Revenue
    $458.44K
    +240.6%
    Net income
    -$2.31M
    N/M
    EPS
    -$0.05
    N/M
  2. Q1 2026May 14, 2026, after the close0.4%by the close of May 15
    Revenue
    $186.98K
    —
    Net income
    -$2.59M
    N/M
    EPS
    -$0.05
    N/M
  3. Q4 2025Feb 20, 2026, before the openThe release4.8%by the close of Feb 20
    Revenue
    —
    —
    Net income
    -$2.80M
    N/M
    EPS
    —
    —
  4. Q3 2025Nov 12, 2025, after the close3.7%by the close of Nov 13
    Revenue
    $123.32K
    —
    Net income
    -$3.05M
    N/M
    EPS
    -$0.06
    N/M

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q2 2026Jun 30, 2026—Aug 13, 202644 d10-Q$458.44K+240.6%-$0.05+0.4%
Q1 2026Mar 31, 2026—May 14, 202644 d10-Q$186.98K—-$0.050.4%
FY 2025
Q4 2025derivedDec 31, 2025Feb 20, 2026 · pre-marketMar 10, 202669 d10-K———4.8%
Q3 2025Sep 30, 2025—Nov 12, 202543 d10-Q$123.32K—-$0.063.7%
Q2 2025Jun 30, 2025—Aug 14, 202545 d10-Q$134.60K—-$0.07—
Q1 2025Mar 31, 2025—May 13, 202543 d10-Q——-$0.06—
FY 2024
Q4 2024derivedDec 31, 2024—Feb 19, 202550 d10-K———7.9%
Q3 2024Sep 30, 2024—Nov 13, 202444 d10-Q——-$0.067.0%
Q2 2024Jun 30, 2024—Aug 8, 202439 d10-Q——-$0.05—
Q1 2024Mar 31, 2024—May 9, 202439 d10-Q——-$0.06—
Earlier years, FY 2010 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QAug 13, 2026349323
10-QMay 14, 2026224066
10-KMar 10, 2026100432
10-QNov 12, 2025277779
10-QAug 14, 2025109041
10-QMay 13, 2025070461
10-KFeb 19, 2025023301
10-QNov 13, 2024126343
10-QAug 8, 2024094092
10-QMay 9, 2024056996

Provenance

ProvenanceData status and checks

Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR